Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Correlation between lymphatic vessel density and microvessel density in cutaneous malignant melanoma.

Toader MP, Ţăranu T, Toader Ş, Chirana A, Ţăranu T.

Rom J Morphol Embryol. 2014;55(1):141-5.

2.
3.

Can lymphatic vascular density be used in determining metastatic spreading potential of tumor in invasive ductal carcinomas?

Kandemir NO, Barut F, Bektas S, Ozdamar SO.

Pathol Oncol Res. 2012 Apr;18(2):253-62. doi: 10.1007/s12253-011-9436-1. Epub 2011 Jul 23.

PMID:
21785902
4.
5.

Lymphatic vessel density is significantly increased in melanoma.

Giorgadze TA, Zhang PJ, Pasha T, Coogan PS, Acs G, Elder DE, Xu X.

J Cutan Pathol. 2004 Nov;31(10):672-7.

PMID:
15491327
6.

Inducible nitric oxide synthase expression in melanoma: implications in lymphangiogenesis.

Massi D, De Nisi MC, Franchi A, Mourmouras V, Baroni G, Panelos J, Santucci M, Miracco C.

Mod Pathol. 2009 Jan;22(1):21-30. doi: 10.1038/modpathol.2008.128. Epub 2008 Jul 25.

7.

Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.

Dadras SS, Paul T, Bertoncini J, Brown LF, Muzikansky A, Jackson DG, Ellwanger U, Garbe C, Mihm MC, Detmar M.

Am J Pathol. 2003 Jun;162(6):1951-60.

8.

Expression pattern of the lymphatic and vascular markers VEGFR-3 and CD31 does not predict regional lymph node metastasis in cutaneous melanoma.

Wobser M, Siedel C, Schrama D, Bröcker EB, Becker JC, Vetter-Kauczok CS.

Arch Dermatol Res. 2006 Feb;297(8):352-7. Epub 2006 Jan 3.

PMID:
16395613
9.

Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva.

Heindl LM, Hofmann-Rummelt C, Adler W, Bosch JJ, Holbach LM, Naumann GO, Kruse FE, Cursiefen C.

Ophthalmology. 2011 Dec;118(12):2351-60. doi: 10.1016/j.ophtha.2011.05.025. Epub 2011 Aug 11.

PMID:
21835473
10.

Prognostic significance of intratumoral and peritumoral lymphatic density and blood vessel density in invasive breast carcinomas.

El-Gohary YM, Metwally G, Saad RS, Robinson MJ, Mesko T, Poppiti RJ.

Am J Clin Pathol. 2008 Apr;129(4):578-86. doi: 10.1309/2HGNJ1GU57JMBJAQ.

PMID:
18343785
11.

Increased Angiogenesis and Lymphangiogenesis in Metastatic Sentinel Lymph Nodes Is Associated With Nonsentinel Lymph Node Involvement and Distant Metastasis in Patients With Melanoma.

Pastushenko I, Van den Eynden GG, Vicente-Arregui S, Prieto-Torres L, Alvarez-Alegret R, Querol I, Dirix LY, Carapeto FJ, Vermeulen PB, Van Laere SJ.

Am J Dermatopathol. 2016 May;38(5):338-46. doi: 10.1097/DAD.0000000000000488.

PMID:
26909582
12.

Peritumoral lymphatic invasion is associated with regional lymph node metastases in prostate adenocarcinoma.

Roma AA, Magi-Galluzzi C, Kral MA, Jin TT, Klein EA, Zhou M.

Mod Pathol. 2006 Mar;19(3):392-8.

13.

Lateral peritumoral lymphatic vessel invasion can predict lymph node metastasis in esophageal squamous cell carcinoma.

Mori D, Yamasaki F, Shibaki M, Tokunaga O.

Mod Pathol. 2007 Jun;20(6):694-700. Epub 2007 Apr 27.

14.

Increased intratumoral lymphatic vessel density correlates with lymph node metastasis in early gastric carcinoma.

Lee K, Park DJ, Choe G, Kim HH, Kim WH, Lee HS.

Ann Surg Oncol. 2010 Jan;17(1):73-80. doi: 10.1245/s10434-009-0707-y. Epub 2009 Sep 24.

PMID:
19777179
15.

Intratumoral but not peritumoral lymphatic vessel density measured by D2-40 expression predicts poor outcome in gastric cancer--ROC curve analysis to find cut-off point.

Donizy P, Rudno-Rudzinska J, Halon A, Dziegala M, Kabarowski J, Frejlich E, Dziegiel P, Kielan W, Matkowski R.

Anticancer Res. 2014 Jun;34(6):3113-8.

PMID:
24922680
16.

Intratumoral lymphatics and lymphatic vessel invasion detected by D2-40 are essential for lymph node metastasis in bladder transitional cell carcinoma.

Ma Y, Hou Y, Liu B, Li X, Yang S, Ma J.

Anat Rec (Hoboken). 2010 Nov;293(11):1847-54. doi: 10.1002/ar.21217.

17.

Blood microvessel density, lymphatic microvessel density and lymphatic invasion in predicting melanoma metastases: systematic review and meta-analysis.

Pastushenko I, Vermeulen PB, Carapeto FJ, Van den Eynden G, Rutten A, Ara M, Dirix LY, Van Laere S.

Br J Dermatol. 2014 Jan;170(1):66-77. doi: 10.1111/bjd.12688. Review.

PMID:
24134623
18.

Lymphatic vessel density as a prognostic marker in clinical stage I endocervical adenocarcinoma.

Saad RS, Ismiil N, Ghorab Z, Nofech-Mozes S, Dubé V, Covens A, Khalifa MA.

Int J Gynecol Pathol. 2010 Jul;29(4):386-93. doi: 10.1097/PGP.0b013e3181c3cd47.

PMID:
20567154
19.

Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression.

Choi WW, Lewis MM, Lawson D, Yin-Goen Q, Birdsong GG, Cotsonis GA, Cohen C, Young AN.

Mod Pathol. 2005 Jan;18(1):143-52.

20.

Relationship between high density of peritumoral lymphatic vessels and biological behavior of cervical cancer.

En-Lin S, Wei-Wei Y, Xiao-Liang X, Juan X.

Int J Gynecol Cancer. 2012 Oct;22(8):1435-41.

PMID:
22968518

Supplemental Content

Support Center